 |
|
|
 |
|
Rationale:
- PTSD often is associated with mood and anxiety symptoms, substance abuse, and interpersonal conflicts.
- If not detected, treatment outcomes may be poor.
|
|
Evidence:
- Patients with mood and anxiety disorders, substance abuse, and family violence have an increased prevalence of PTSD, and vice
versa (1; 2; 3; 7; 8; 9).
|
|
Comments:
- The comorbidity among PTSD, other psychiatric disorders, and medical illnesses can create difficult diagnostic problems. Undetected
PTSD may be the reason for a poor outcome when treating other psychiatric illnesses. A high index of suspicion for PTSD and
a systematic approach to diagnosis are essential.
|
| FAQs |
|
|
|
Jeffrey P. Staab, MD, MS, is a consultant for Eli Lilly, Forest Laboratories, received honorarium from Abbott Laboratories, received grants from GlaxoSmithKline,
Pfizer. Michael Roy, MD, editorial consultant, received honorarium from PFizer.
|
|
|
|
The information included herein should never be used as a substitute
for clinical judgment and does not represent an official position of
ACP. Because all PIER modules are updated regularly, printed web pages
or PDFs may rapidly become obsolete. Therefore, PIER users should
compare the date of the last update on the website with any printout
to ensure that the information being referred to is the most current
available.
|
PIER is copyrighted (c) 2008 by the American College of Physicians,
190 N. Independence Mall West, Philadelphia, PA 19106-1572, USA.
|
|
|
Posttraumatic Stress Disorder
> Screening
